Search research articles
Contact Us
Filters
Showing results (31-40 of 466) with videos related to
Page
of 47
Sort By:
Virulence
|
February 12, 2016
Bloodstream infections in patients with liver cirrhosis
Michele Bartoletti, Maddalena Giannella, Russell Edward Lewis, et al.
The Pediatric Infectious Disease Journal
|
October 21, 2015
Use of Daptomycin in Critically Ill Children With Bloodstream Infections and Complicated Skin and Soft-tissue Infections
Sara Tedeschi, Fabio Tumietto, Matteo Conti, et al.
International Journal of Antimicrobial Agents
|
December 7, 2023
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
The Journal of Antimicrobial Chemotherapy
|
March 26, 2003
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose
Federico Pea, Loris Brollo, Pierluigi Viale, et al.
Therapeutic Drug Monitoring
|
August 8, 2024
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples
Matteo Conti, Beatrice Giorgi, Milo Gatti, et al.
British Journal of Clinical Pharmacology
|
November 7, 2022
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies
Milo Gatti, Giacomo Fornaro, Pierluigi Viale, et al.
Infectious Diseases and Therapy
|
September 13, 2015
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Pierluigi Viale, Maddalena Giannella, Michele Bartoletti, et al.
Expert Review of Anti-Infective Therapy
|
September 28, 2019
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections
Renato Pascale, Maddalena Giannella, Michele Bartoletti, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 2006
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective
Federico Pea, Donatella Poz, Pierluigi Viale, et al.
Microorganisms
|
January 25, 2025
Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible <i>Enterococcus faecium</i>
Milo Gatti, Matteo Rinaldi, Maddalena Giannella, et al.
Page
of 47
Search research articles
Search
Showing results (31-40 of 466) with videos related to
Sort By:
Page
of 47
Virulence
|
February 12, 2016
Bloodstream infections in patients with liver cirrhosis
Michele Bartoletti, Maddalena Giannella, Russell Edward Lewis, et al.
The Pediatric Infectious Disease Journal
|
October 21, 2015
Use of Daptomycin in Critically Ill Children With Bloodstream Infections and Complicated Skin and Soft-tissue Infections
Sara Tedeschi, Fabio Tumietto, Matteo Conti, et al.
International Journal of Antimicrobial Agents
|
December 7, 2023
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
The Journal of Antimicrobial Chemotherapy
|
March 26, 2003
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose
Federico Pea, Loris Brollo, Pierluigi Viale, et al.
Therapeutic Drug Monitoring
|
August 8, 2024
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples
Matteo Conti, Beatrice Giorgi, Milo Gatti, et al.
British Journal of Clinical Pharmacology
|
November 7, 2022
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies
Milo Gatti, Giacomo Fornaro, Pierluigi Viale, et al.
Infectious Diseases and Therapy
|
September 13, 2015
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Pierluigi Viale, Maddalena Giannella, Michele Bartoletti, et al.
Expert Review of Anti-Infective Therapy
|
September 28, 2019
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections
Renato Pascale, Maddalena Giannella, Michele Bartoletti, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 2006
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective
Federico Pea, Donatella Poz, Pierluigi Viale, et al.
Microorganisms
|
January 25, 2025
Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible <i>Enterococcus faecium</i>
Milo Gatti, Matteo Rinaldi, Maddalena Giannella, et al.
Page
of 47